A new analysis of bot/bal in metastatic MSS colorectal cancer at ASCO24 – Agenus

Agenus recently shared a post on LinkedIn:

“Agenus is headed to ASCO24 where Dr. Marwan Fakih will share a new analysis that highlights botensilimab/balstilimab’s activity across challenging metastatic disease sites in MSS colorectal cancer. Learn more about the data and upcoming presentation.”